Holding(s) in Company

RNS Number : 3603J
Dechra Pharmaceuticals PLC
04 December 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i


1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Dechra Pharmaceuticals plc

1b. Please indicate if the issuer is a non-UK issuer  (please mark with an "X" if appropriate)

Non-UK issuer


2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

X

An event changing the breakdown of voting rights


Other (please specify)iii:   


3. Details of person subject to the notification obligationiv

Name

Aviva plc & its subsidiaries    

City and country of registered office (if applicable)

London, England

4. Full name of shareholder(s) (if different from 3.)v

Name

Registered Holder:

 

Available on Request                                           1,409*

 

Chase (GA Group) Nominees Limited         1,165,143*

 

Chase Nominees Limited                                  18,472*

HSBC Global Custody Nominee (UK) Limited    729,173*

State Street Nominees Limited                        21,426*

            * denotes direct interest

City and country of registered office (if applicable)


5. Date on which the threshold was crossed or reachedvi:

30/11/2018

03/12/2018


% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments
(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

1.88%

1.11%

2.99%

102,500,359

Position of previous notification (if

applicable)

2.99%

0.08%

3.07%


 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

ISIN code (if possible)

Number of voting rightsix

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares


GB0009633180

1,935,623

Not Disclosable

 1.88%

Not Disclosable











1,935,623

1.88%


Expiration
date
x

Exercise/
Conversion Period
xi

RIGHT TO RECALL LOANED SHARES

N/A

N/A

1,138,776*

 

* DIRECT INTEREST

1.11%








1,138,776

1.11%

 

 

Expiration
date
x

Exercise/
Conversion Period
xi

settlementxii


















 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii


Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity
xiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Aviva plc




Aviva Group Holdings Limited



 

Aviva Investors Holdings Limited



 

Aviva Investors Global Services Limited



 





Aviva plc




Aviva Group Holdings Limited




Friends Provident

International Limited




10. In case of proxy voting, please identify:

Name of the proxy holder

See Section 4

The number and % of voting rights held


The date until which the voting rights will be held


 

 

 

 

11. Additional informationxvi

This notification is prompted by a 3% to <3% change at Direct Interest Level (Box 8A and 8B)

 

Norwich, England

03 December 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLDMMGZRDLGRZG
UK 100

Latest directors dealings